Lv31
278 积分 2020-08-11 加入
AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
2小时前
待确认
A general perspective for the conduct of radiolabelled distribution, metabolism, and excretion studies for antibody-drug conjugates
8天前
已完结
Time-dependent population PK models of single-agent atezolizumab in patients with cancer
2个月前
已完结
Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective
2个月前
已完结
Association between perfluoroalkyl substances and breast cancer on the National Health and Nutrition Examination Survey Database and meta-analysis
3个月前
已完结
“Getting the Dose Right”—Revisiting the Topic With Focus on Biologic Agents
3个月前
已完结
Review of the Clinical Pharmacokinetics, Efficacy and Safety of Pembrolizumab
3个月前
已完结
Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes
5个月前
已完结
Trastuzumab Deruxtecan Dosing in Human Epidermal Growth Factor Receptor 2‐Positive Gastric Cancer: Population Pharmacokinetic Modeling and Exposure–Response Analysis
5个月前
已完结
A survey of FDA Approved Monoclonal Antibodies and Fc-fusion Proteins for Manufacturing Changes and Comparability Assessment
6个月前
已完结
皖公网安备34019202002308
